Oncology Institute (TOI) Stock Forecast, Price Target & Predictions
TOI Stock Forecast
Oncology Institute stock forecast is as follows: an average price target of $8.00 (represents a 5951.44% upside from TOI’s last price of $0.13) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
TOI Price Target
The average price target for Oncology Institute (TOI) is $8.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $10.00 to $6.00. This represents a potential 5951.44% upside from TOI's last price of $0.13.
TOI Analyst Ratings
According to 2 Wall Street analysts, Oncology Institute's rating consensus is 'Buy'. The analyst rating breakdown for TOI stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Oncology Institute Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 11, 2022 | - | Guggenheim | $6.00 | $2.50 | 140.10% | 4438.58% |
| Aug 15, 2022 | - | Jefferies | $10.00 | $6.44 | 55.28% | 7464.30% |
The latest Oncology Institute stock forecast, released on Nov 11, 2022 by Guggenheim company, set a price target of $6.00, which represents a 140.10% increase from the stock price at the time of the forecast ($2.50), and a 4438.58% increase from TOI last price ($0.13).
Oncology Institute Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $0.13 | $0.13 | $0.13 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Oncology Institute stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Oncology Institute's last price of $0.13. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 11, 2022 | Guggenheim | Buy | Buy | Hold |
| Aug 15, 2022 | Jefferies | - | Buy | Initialise |
Oncology Institute's last stock rating was published by Guggenheim on Nov 11, 2022. The company gave TOI a "Buy" rating, the same as its previous rate.
Oncology Institute Financial Forecast
Oncology Institute Revenue Forecast
| Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | $85.79M | $82.03M | $80.22M | $76.19M | $71.42M | $64.98M |
| Avg Forecast | $109.15M | $107.54M | $103.31M | $95.17M | $82.04M | $74.66M | $73.80M | $65.00M | $64.73M | $68.95M |
| High Forecast | $109.15M | $107.54M | $103.31M | $95.17M | $82.04M | $74.66M | $73.80M | $65.00M | $64.73M | $68.95M |
| Low Forecast | $109.15M | $107.54M | $103.31M | $95.17M | $82.04M | $74.66M | $73.80M | $65.00M | $64.73M | $68.95M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | 1.05% | 1.10% | 1.09% | 1.17% | 1.10% | 0.94% |
Oncology Institute's average Quarter revenue forecast for Mar 24 based on 1 analysts is $95.17M, with a low forecast of $95.17M, and a high forecast of $95.17M. TOI's average Quarter revenue forecast represents a 10.93% increase compared to the company's last Quarter revenue of $85.79M (Dec 23).
Oncology Institute EBITDA Forecast
| Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | $-15.15M | $-13.16M | $-12.99M | $-13.38M | $-13.27M | $-19.00M |
| Avg Forecast | $-6.14M | $-6.05M | $-5.81M | $-5.35M | $-4.62M | $-4.20M | $-4.15M | $-3.66M | $-3.64M | $-9.59M |
| High Forecast | $-6.14M | $-6.05M | $-5.81M | $-5.35M | $-4.62M | $-4.20M | $-4.15M | $-3.66M | $-3.64M | $-9.59M |
| Low Forecast | $-6.14M | $-6.05M | $-5.81M | $-5.35M | $-4.62M | $-4.20M | $-4.15M | $-3.66M | $-3.64M | $-9.59M |
| Surprise % | - | - | - | - | 3.28% | 3.13% | 3.13% | 3.66% | 3.64% | 1.98% |
undefined analysts predict TOI's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Oncology Institute's previous annual EBITDA (undefined) of $NaN.
Oncology Institute Net Income Forecast
| Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | $-18.75M | $-17.42M | $-16.90M | $-30.00M | $-9.50M | $-2.67M |
| Avg Forecast | $-6.04B | $-5.29B | $-6.80B | $-9.06B | $-8.31B | $-9.82B | $-12.84B | $-12.84B | $-15.10B | $-13.45M |
| High Forecast | $-6.04B | $-5.29B | $-6.80B | $-9.06B | $-8.31B | $-9.82B | $-12.84B | $-12.84B | $-15.10B | $-13.45M |
| Low Forecast | $-6.04B | $-5.29B | $-6.80B | $-9.06B | $-8.31B | $-9.82B | $-12.84B | $-12.84B | $-15.10B | $-13.45M |
| Surprise % | - | - | - | - | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.20% |
Oncology Institute's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. TOI's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Oncology Institute SG&A Forecast
| Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | $28.09M | $28.20M | $28.73M | $28.83M | $29.57M | $31.96M |
| Avg Forecast | $36.02M | $35.49M | $34.09M | $31.40M | $27.07M | $24.64M | $24.35M | $21.45M | $21.36M | $22.75M |
| High Forecast | $36.02M | $35.49M | $34.09M | $31.40M | $27.07M | $24.64M | $24.35M | $21.45M | $21.36M | $22.75M |
| Low Forecast | $36.02M | $35.49M | $34.09M | $31.40M | $27.07M | $24.64M | $24.35M | $21.45M | $21.36M | $22.75M |
| Surprise % | - | - | - | - | 1.04% | 1.14% | 1.18% | 1.34% | 1.38% | 1.40% |
Oncology Institute's average Quarter SG&A projection for Mar 24 is $31.40M, based on 1 Wall Street analysts, with a range of $31.40M to $31.40M. The forecast indicates a 11.80% rise compared to TOI last annual SG&A of $28.09M (Dec 23).
Oncology Institute EPS Forecast
| Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | $-0.26 | $-0.24 | $-0.00 | $-0.41 | $-0.13 | $-0.04 |
| Avg Forecast | $-0.08 | $-0.07 | $-0.09 | $-0.12 | $-0.11 | $-0.13 | $-0.17 | $-0.17 | $-0.20 | $-0.18 |
| High Forecast | $-0.08 | $-0.07 | $-0.09 | $-0.12 | $-0.11 | $-0.13 | $-0.17 | $-0.17 | $-0.20 | $-0.18 |
| Low Forecast | $-0.08 | $-0.07 | $-0.09 | $-0.12 | $-0.11 | $-0.13 | $-0.17 | $-0.17 | $-0.20 | $-0.18 |
| Surprise % | - | - | - | - | 2.36% | 1.85% | 0.00% | 2.41% | 0.65% | 0.21% |
According to undefined Wall Street analysts, Oncology Institute's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to TOI previous annual EPS of $NaN (undefined).
Oncology Institute Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| TOI | Oncology Institute | $0.13 | $8.00 | 6053.85% | Buy |
| CANO | Cano Health | $2.30 | $6.42 | 179.13% | Buy |
| AGL | agilon health | $1.67 | $4.40 | 163.47% | Buy |
| SGRY | Surgery Partners | $22.51 | $40.80 | 81.25% | Buy |
| JYNT | Joint | $11.35 | $20.00 | 76.21% | Buy |
| BKD | Brookdale Senior Living | $5.22 | $7.50 | 43.68% | Buy |
| MD | Pediatrix Medical Group | $14.49 | $18.17 | 25.40% | Hold |
| PNTG | Pennant Group | $30.78 | $34.67 | 12.64% | Buy |
| ADUS | Addus HomeCare | $120.99 | $132.80 | 9.76% | Buy |
| UHS | Universal Health Services | $197.52 | $208.47 | 5.54% | Hold |
| SEM | Select Medical | $38.09 | $40.00 | 5.01% | Buy |
| ENSG | Ensign Group | $144.66 | $148.20 | 2.45% | Buy |
| EHC | Encompass Health | $98.93 | $97.00 | -1.95% | Buy |
| SNDA | Sonida Senior Living | $23.77 | $13.00 | -45.31% | Sell |